GLG helped a biotech company plan for the demand of a new drug/device combination by commissioning a forecasting study that combined qualitative and quantitative methodologies.
Dedicated Service
GLG identified and staffed the project leads: an experienced market researcher and a former operating executive with industry experience in the neurology subsector.
Best-in-Class Populations
GLG sourced 20 KOL-level neurologists for qualitative interviews and 70 neurologists for an online survey.
Challenge
Our client, a recently acquired biotech company, needed an independent and unbiased 5-to-10-year forecast to present to their parent company on a 3-week timeline.
To advocate for the required investment level needed, they came to GLG looking to commission an independent forecast that included projected client demand in various patient segments and projected U.S. sales in different competitor scenarios.
The GLG Approach
GLG staffed a project team to conduct secondary research on the competitive landscape so that they could develop qualitative and quantitative questionnaires to assess adoption rates by various patient segments.
Once the client approved the questionnaires, the project team conducted qualitative interviews with 20 neurologists to identify adoption and competitive dynamics hypotheses and collected responses from 70 neurologists to assess adoption potential in key patient segments with an online survey.
Outcome
Within three weeks of launch, the project team provided the client with: current and future market size, projected 5-to-10-year net sales, target patient segmentation, and key success launch factors.
아래에 연락처 정보를 입력해 주시면 담당 팀원이 곧 연락드리겠습니다.
.avif)
